| scholarly article | Q13442814 |
| P50 | author | Samart Pakakasama | Q87693246 |
| P2093 | author name string | Duangrurdee Wattanasirichaigoon | |
| Anant Khositseth | |||
| Lulin Choubtuym | |||
| Suwadee Jirasakpisarn | |||
| P2860 | cites work | Plasma carnitine concentrations in patients undergoing open heart surgery | Q44791613 |
| Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria | Q46667328 | ||
| The echocardiographic Tei-index reflects early myocardial damage induced by anthracyclines in patients with hematological malignancies | Q46878276 | ||
| Captopril ameliorates myocardial and hematological toxicities induced by adriamycin | Q47790508 | ||
| New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy | Q47897197 | ||
| Assessment of global left ventricular function in normal children and in children with dilated cardiomyopathy. | Q52172744 | ||
| Long-term 1-carnitine treatment prolongs the survival in rats with adriamycin-induced heart failure | Q71959375 | ||
| [Echocardiographic evaluation of cardiotoxicity induced by anthracycline therapy] | Q73190763 | ||
| Risk factors for doxorubicin-induced congestive heart failure | Q28328220 | ||
| Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine | Q28373598 | ||
| The role of iron in doxorubicin-induced cardiomyopathy. | Q30472660 | ||
| Adriamycin—A Review | Q34081232 | ||
| Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review | Q36870241 | ||
| Determination of L-carnitine, acylcarnitine and total carnitine levels in plasma and tissues of camel (Camelus dromedarius). | Q38868569 | ||
| l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism | Q39669492 | ||
| Subcellular effects of adriamycin in the heart: a concise review | Q39686848 | ||
| Cardiotoxicity of antitumor agents | Q40190664 | ||
| L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. | Q42476763 | ||
| Effect of L-carnitine on myocardial metabolism: results of a balanced, placebo-controlled, double-blind study in patients undergoing open heart surgery | Q42542820 | ||
| Serum carnitine levels of pediatric cancer patients | Q43852232 | ||
| Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity. | Q44083090 | ||
| Effect of L-carnitine supplementation on cardiac carnitine palmitoyltransferase activities and plasma carnitine concentrations in adriamycin-treated rats | Q44350861 | ||
| Study on the effect of doxorubicin on expressions of genes encoding myocardial sarcoplasmic reticulum Ca2+ transport proteins and the effect of taurine on myocardial protection in rabbits | Q44375365 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | doxorubicin | Q18936 |
| P304 | page(s) | 38-42 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Indian Journal of Medical and Paediatric Oncology | Q15710014 |
| P1476 | title | Carnitine levels and cardiac functions in children with solid malignancies receiving doxorubicin therapy | |
| P478 | volume | 32 |
| Q89462674 | Association between carnitine deficiency and the erythropoietin resistance index in patients undergoing peritoneal dialysis: a cross-sectional observational study |
| Q33739871 | Carnitine and cardiac dysfunction in childhood cancer survivors treated with anthracyclines |
| Q48251436 | Carnitine partially improves oxidative stress, acrosome integrity, and reproductive competence in doxorubicin-treated rats |
Search more.